Theriva Biologics (TOVX) Exchange Rate Effect (2022 - 2026)
Theriva Biologics (TOVX) posted quarterly Exchange Rate Effect of -$36000.0 for Q1 2026, down 138.71% year-over-year from $93000.0 in Q1 2025, and up 25.0% quarter-over-quarter from -$48000.0 in Q4 2025.
Theriva Biologics (TOVX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Exchange Rate Effect for 5 consecutive years, with -$36000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 138.71% year-over-year to -$36000.0; the TTM figure through Mar 2026 stood at -$221000.0 (down 22000.0% YoY), while the FY2025 annual figure was -$92000.0, up 30.3% from the prior year.
- Exchange Rate Effect improved to -$36000.0 in Q1 2026 per TOVX's latest filing, from -$48000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $93000.0 in Q1 2025 and bottomed at -$123000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$19117.6 across 5 years, with a median of -$35000.0 in 2023.
- On a YoY basis, Exchange Rate Effect climbed as much as 344.74% in 2025 and fell as far as 723.53% in 2025.
- Theriva Biologics' Exchange Rate Effect stood at $52000.0 in 2022, then jumped by 46.15% to $76000.0 in 2023, then slumped by 261.84% to -$123000.0 in 2024, then soared by 60.98% to -$48000.0 in 2025, then climbed by 25.0% to -$36000.0 in 2026.
- Business Quant data shows TOVX's Exchange Rate Effect at -$36000.0 in Q1 2026, -$48000.0 in Q4 2025, and -$106000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Theriva Biologics | 10.90 Mn | 10.90 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | -48,000.00 |
| Dec 31, 2025 | -48,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | -123,000.00 |
| Dec 31, 2024 | -123,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Mar 31, 2024 | -38,000.00 |